Clinical features and treatment of activated PI3K-delta syndrome in Peruvian children: A case series

被引：0

作者：

Toribio-Dionicio, Crhistian ^{[1
]}

Eliana Veramendi-Espinoza, Liz ^{[2
]}

Luna-Peralta, Gerardo ^{[3
]}

Gavino-Alarcon, Franz ^{[4
]}

Jara-Rodas, Catherine ^{[3
]}

Cordova-Calderon, Wilmer ^{[5
]}

Carlos Aldave, Juan ^{[2
]}

机构：

[1] New York Med Coll, Metropolitan Hosp Ctr, New York, NY USA

[2] Hosp Nacl Edgardo Rebagliati Martin, Allergy & Immunol Div, Lima, Peru

[3] Univ Nacl Mayor San Marcos, Sociedad Cientif San Fernando, Lima, Peru

[4] Univ Nacl Mayor San Marcos, Fac Med, Lima, Peru

[5] Inst Nacl Salud Nino, Funct Unit Allergy Asthma & Immunol, Brena, Peru

来源：

CLINICAL IMMUNOLOGY | 2023年 / 250卷

关键词：

Activated PI3K-delta syndrome; Inborn error of immunity; Clinical manifestation; Pediatric; Peru;

D O I：

10.1016/j.clim.2023.109382

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：8 / 8

页数：1

共 50 条

[31] Phase 3 Placebo-Controlled, Randomized Clinical Trial Outcomes of PI3K Delta Inhibitor Leniolisib in Patients with Activated PI3K Delta Syndrome (APDS/PASLI)
Rao, V. Koneti
Webster, Sharon
Sediva, Anna
Plebani, Alessandro
Schuetz, Catharina
Shcherbina, Anna
Conlon, Niall
Coulter, Tanya
Dalm, Virgil
Trizzino, Antonino
Zharankova, Yulia
Kulm, Elaine
Koerholz, Julia
Lougaris, Vassilios
Rodina, Yulia
Kucher, Klaus
Radford, Kath
Bradt, Jason
Uzel, Gulbu
JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S4 - S5
[32] Activated PI3Kδ syndrome
Stretton, Owen
LANCET HAEMATOLOGY, 2022, 9 (08): : E557 - E557
[33] PI3K-Delta Inhibitors Induce Primary Monocyte Cytotoxicity but Do Not Alter Monocyte Differentiation
Friedman, Daphne
Volkheimer, Alicia
Guadalupe, Eross
Maryanski, Dave
Miskin, Hari P.
Weinberg, J. Brice
BLOOD, 2017, 130
[34] The MEK-inhibitor pimasertib is synergistic with PI3K-delta and BTK inhibitors in lymphoma models
Gaudio, Eugenio
Tarantelli, Chiara
Barassi, Chiara
Bernasconi, Elena
Kwee, Ivo
Cascione, Luciano
Ponzoni, Maurilio
Rinaldi, Andrea
Stathis, Anastasios
Goodstal, Samantha
Zucca, Emanuele
Bertoni, Francesco
CANCER RESEARCH, 2015, 75
[35] Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome
Nademi, Zohreh
Slatter, Mary
Dvorak, Christopher
Neven, Benedicte
Fischer, Alain
Suarez, Felipe
Booth, Claire
Rao, Kanchan
Laberko, Alexandra
Rodina, Julia
Bertrand, Yves
Koltan, Sylwia
Debski, Robert
Flood, Terence
Abinun, Mario
Gennery, Andrew R.
Hambleton, Sophie
Ehl, Stephan
Cant, Andrew
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (03) : 1046 - 1049
[36] ESTIMATED ANNUAL COSTS AMONG PATIENTS WITH ACTIVATED PI3K DELTA SYNDROME
Harrington, A.
Hartog, N. L.
Wu, E. Y.
Rider, N. L.
Aggarwal, S.
VALUE IN HEALTH, 2023, 26 (06) : S115 - S115
[37] SUCCESSFUL CLINICAL STUDY OF LENIOLISIB (CDZ173), A SMALL MOLECULE PI3K-DELTA INHIBITOR, IN PATIENTS WITH APDS/PASLI
Rao, V. Koneti
Christ, Andreas
Su, Hua
Kashyap, Anuj
Webster, Sharon
Sediva, Anna
Dalm, Virgil A. S. H.
Van Hagen, P. Martin
Sloth, Birgitte
Lenardo, Michael J.
Cabanski, Maciej
Burkhart, Christoph
Uzel, Gulbu
JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (02) : 204 - 204
[38] Psoriasiform Eruption Secondary to PI3K-delta Inhibitor: Expanding the Spectrum of Psoriasiform Paradoxical Reactions?
Pesque, David
Sanchez-Gonzalez, Blanca
Gallardo, Fernando
Segura, Sonia
Maria Pujol, Ramon
ACTA DERMATO-VENEREOLOGICA, 2021, 101
[39] Activated PI3Kδ syndrome - reviewing challenges in diagnosis and treatment
Vanselow, Sven
Wahn, Volker
Schuetz, Catharina
FRONTIERS IN IMMUNOLOGY, 2023, 14
[40] Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome
Thauland, Timothy J.
Pellerin, Laurence
Ohgami, Robert S.
Bacchetta, Rosa
Butte, Manish J.
FRONTIERS IN IMMUNOLOGY, 2019, 10

← 1 2 3 4 5 →